Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21709994 | 0.75 | ALDH1A1 (0.40) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL6912914 | 0.72 | NOX1 (0.42) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL30291021 | 0.72 | GAA (0.47) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL8931208 | 0.71 | EGFR (0.36) | CYP3A4MAOA | |
| SCHEMBL21635988 | 0.69 | POLB (0.36) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL30291096 | 0.65 | — | — | |
| SCHEMBL30291028 | 0.64 | MEN1 (0.37) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL13752017 | 0.64 | AVPR1A (0.34) | — | |
| SCHEMBL20539744 | 0.64 | NOX1 (0.48) | MEN1CYP1A2BCHEPOLBCYP3A4 | |
| SCHEMBL10824601 | 0.61 | HDAC4 (0.33) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | disclosed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | disclosed |
| US-20130105297-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2013-05-02 | — | — | US | disclosed |
| US-8030368-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2011-10-04 | — | — | US | disclosed |
| US-7402374-B2 | Method for colored image formation | FUJIFILM CORPORATION (JP) | 2008-07-22 | — | — | US | disclosed |
| US-7402374-B2 | Method for colored image formation | FUJIFILM CORPORATION (JP) | 2008-07-22 | — | — | US | disclosed |
| EP-1602480-B1 | Method for colored image formation | FUJIFILM CORP (JP) | 2007-12-12 | — | — | EP | disclosed |
| US-20070185225-A1 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | MEN1 3463/4885CYP1A2 40/4885BCHE 553/4885 |
| US-20130105297-A1 | PHOTOINITIATED REACTIONS | KMO, DECR1, DDT | MEN1 3467/4885CYP1A2 38/4885BCHE 531/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | MEN1 3965/4885CYP1A2 398/4885BCHE 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.